Cancer clinical trial recruitment drops by 60% during the pandemic

Hospital Pharmacy Europe reported that the number of cancer patients entering clinical trials has fallen drastically during the pandemic. This has created problems accessing treatment options, and delaying the development of innovative drugs and technologies. The National Institute for Health Research (NIHR) has also reported that the number of patients recruited onto cancer clinical trials […]

read more

One Cancer Voice: Plotting a route out of the pandemic

On Saturday 9 October, the Daily Mail ran a piece from One Cancer Voice urging the government to commit much-needed funding to improve and maintain cancer services. KCSN was one of the 47 cancer charities lobbying for this change. COVID-19 has impacted cancer services and halted progress, delaying both diagnosis and treatment. Although most services […]

read more

ESMO 2021: Cancer and COVID-19: Outcomes and risk factors

This year there was some very important data presented at the ESMO 2021 virtual meeting regarding COVID-19 and cancer. We have been dealing with this pandemic for a long time, and researchers have been working hard to generate data that can inform clinical decisions regarding the outcomes and risk factors in patients with cancer and […]

read more

55,000 cancer patients miss treatment target over 6 years

Cancer Research UK has reported that over the past 6 years, almost 55,000 cancer patients have missed the 62-day wait for treatment. The key reasons for this are shortages in workforce and diagnostic equipment. These patients should have been diagnosed quicker and started treatment sooner. However, the government’s own target of 85% of cancer patients […]

read more

ESMO 2021: COVID-19 vaccine in cancer patients is comparable to the general population

The latest findings from five studies presented at the ESMO Congress 2021 help cut short the debate on the safety and efficacy of COVID vaccines in cancer patients and re-affirm ESMO’s recommendations for early vaccination of this high-priority population, as outlined in the ESMO ten statements, which were updated in April 2021. Patients with cancer or a history […]

read more

NHS England to trial new blood test for over 50 types of cancer

NHS England is about to start a large-scale trial of a new blood test that can detect over 50 types of early stage cancer. The test is called the Galleri test, and is able to identify early signs of cancer in the blood before people start to experience symptoms. The test has been shown to […]

read more

The link between physical exercise and cancer

Physical activity has many benefits, including increasing the chance of living a healthy life beyond retirement, lowering the risk of being overweight, improving mental health, and lowering the risk for various diseases, including cancer. Various observational studies, a type of study in which individuals are observed or certain outcomes are measured, have shown that leisure-time […]

read more

Open letter from cancer charities to the public

Forty (40) charities and organisations have written an open letter, urging the public to help keep vulnerable people safe as restrictions ease. Rose Woodward, Founder and Patient Advocate of KCSN, was one of those who endorsed this letter. The letter was published in The Guardian yesterday: Here is the letter in full: Tomorrow in England […]

read more

Blood test that detects 50 types of cancer

A simple blood test that can detect more than 50 types of cancer is to be piloted by NHS England in the autumn. The test identifies circulating free DNA (cfDNA) from cancer before any clinical signs or symptoms of the disease emerge. It is hoped it will eventually become a screening test for the early […]

read more

Patients with autoimmune disorders have more immune-related side effects to immunotherapy

A study published in The Oncologist recently shows that patients with pre-existing autoimmune disorders are at an increased risk of developing immune-related side effects when treated with immunotherapy. This is regardless of tumour type, gender and general wellbeing. However, these patients can still be treated with immunotherapy. The study included 751 patients with four different […]

read more
Showing 1 to 10 of 152 results
  TOP